Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 2.240
+0.150 (7.18%)
At close: Mar 27, 2026
235.33% (1Y)
| Market Cap | 236.35M +150.8% |
| Revenue (ttm) | 167.17M +152.7% |
| Net Income | 91.74M |
| EPS | 0.98 |
| Shares Out | 105.52M |
| PE Ratio | 2.29 |
| Forward PE | 7.47 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 800,552 |
| Average Volume | 567,335 |
| Open | 2.040 |
| Previous Close | 2.090 |
| Day's Range | 2.040 - 2.260 |
| 52-Week Range | 0.360 - 2.350 |
| Beta | -0.62 |
| RSI | 64.44 |
| Earnings Date | May 8, 2026 |